NASDAQ:EDIT   EDITAS MEDICINE INC
151 2 5
High end biotech early stage CRISPR .. the bitcoin             of biotech
yea naysayers can suck it now thanks :)
Reply
There are a few efforts to use CRISPR to treat or even cure blindness in humans. Researchers have successfully removed a genetic mutation from mice that causes retinitis pigmentosa, a disease that ultimately leads to blindness. After a single injection of the CRISPR/Cas9 system, the rats were able to see better than a control group. Plans to use a similar technique on humans are already underway. Biotechnology company Editas Medicine is planning to use CRISPR to treat the inherited eye disease leber's congenitial amaurosis (LCA) by 2017.
Reply
United States
United Kingdom
India
Deutschland
France
España
Italia
Polska
Türkiye
Россия
Brasil
Indonesia
Malaysia
ประเทศไทย
Việt Nam
日本
한국
简体
繁體
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out